Investors purchased shares of Anthem Inc (NYSE:ANTM) on weakness during trading on Monday after an insider sold shares in the company. $129.27 million flowed into the stock on the tick-up and $81.42 million flowed out of the stock on the tick-down, for a money net flow of $47.85 million into the stock. Of all equities tracked, Anthem had the 29th highest net in-flow for the day. Anthem traded down ($2.52) for the day and closed at $231.82Specifically, insider Joseph Swedish sold 21,125 shares of Anthem stock in a transaction that occurred on Wednesday, November 1st. The shares were sold at an average price of $209.85, for a total value of $4,433,081.25. Following the completion of the transaction, the insider now owns 87,668 shares in the company, valued at $18,397,129.80. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Gloria M. Mccarthy sold 14,429 shares of Anthem stock in a transaction that occurred on Thursday, January 4th. The stock was sold at an average price of $229.68, for a total transaction of $3,314,052.72. Following the completion of the transaction, the executive vice president now owns 30,667 shares of the company’s stock, valued at approximately $7,043,596.56. The disclosure for this sale can be found here. Insiders sold 59,259 shares of company stock valued at $13,194,281 in the last quarter. 0.36% of the stock is owned by insiders.
ANTM has been the subject of a number of recent research reports. Cantor Fitzgerald reiterated a “buy” rating and issued a $215.00 price target on shares of Anthem in a research note on Wednesday, October 18th. Cowen restated a “buy” rating and set a $160.00 price objective on shares of Anthem in a research report on Thursday, September 21st. Zacks Investment Research upgraded shares of Anthem from a “hold” rating to a “buy” rating and set a $207.00 price objective for the company in a research report on Wednesday, September 20th. BidaskClub upgraded shares of Anthem from a “hold” rating to a “buy” rating in a research report on Thursday, October 26th. Finally, Bank of America boosted their price objective on shares of Anthem from $249.00 to $254.00 and gave the stock a “buy” rating in a research report on Friday, November 17th. Six equities research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. The company has an average rating of “Buy” and a consensus target price of $206.60.
The firm has a market cap of $60,250.00, a PE ratio of 21.22, a price-to-earnings-growth ratio of 1.70 and a beta of 0.79. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.51 and a quick ratio of 1.51.
Anthem (NYSE:ANTM) last announced its earnings results on Wednesday, October 25th. The company reported $2.65 EPS for the quarter, beating analysts’ consensus estimates of $2.40 by $0.25. The business had revenue of $22.10 billion for the quarter, compared to analysts’ expectations of $22.10 billion. Anthem had a net margin of 3.35% and a return on equity of 12.97%. The company’s quarterly revenue was up 4.6% on a year-over-year basis. During the same period in the previous year, the company posted $2.45 EPS. sell-side analysts predict that Anthem Inc will post 11.97 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which was paid on Thursday, December 21st. Stockholders of record on Tuesday, December 5th were issued a $0.70 dividend. The ex-dividend date was Monday, December 4th. This represents a $2.80 dividend on an annualized basis and a dividend yield of 1.19%. Anthem’s payout ratio is 25.32%.
Anthem declared that its Board of Directors has approved a share repurchase plan on Thursday, December 7th that allows the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization allows the company to purchase shares of its stock through open market purchases. Shares repurchase plans are often a sign that the company’s board of directors believes its stock is undervalued.
Several institutional investors have recently made changes to their positions in the company. C M Bidwell & Associates Ltd. increased its holdings in shares of Anthem by 0.5% in the 2nd quarter. C M Bidwell & Associates Ltd. now owns 1,070 shares of the company’s stock valued at $201,000 after acquiring an additional 5 shares during the period. Salem Investment Counselors Inc. increased its holdings in shares of Anthem by 1.4% in the 2nd quarter. Salem Investment Counselors Inc. now owns 710 shares of the company’s stock valued at $134,000 after acquiring an additional 10 shares during the period. Gofen & Glossberg LLC IL increased its holdings in shares of Anthem by 0.6% in the 2nd quarter. Gofen & Glossberg LLC IL now owns 2,540 shares of the company’s stock valued at $478,000 after acquiring an additional 15 shares during the period. Bahl & Gaynor Inc. increased its holdings in shares of Anthem by 11.1% in the 2nd quarter. Bahl & Gaynor Inc. now owns 1,451 shares of the company’s stock valued at $209,000 after acquiring an additional 145 shares during the period. Finally, Sii Investments Inc. WI increased its holdings in shares of Anthem by 5.4% in the 2nd quarter. Sii Investments Inc. WI now owns 2,860 shares of the company’s stock valued at $537,000 after acquiring an additional 147 shares during the period. 87.41% of the stock is currently owned by institutional investors and hedge funds.
TRADEMARK VIOLATION WARNING: This piece was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this piece on another site, it was illegally stolen and republished in violation of US and international trademark and copyright laws. The original version of this piece can be read at https://www.dispatchtribunal.com/2018/01/10/investors-buy-shares-of-anthem-antm-on-weakness-after-insider-selling.html.
Anthem, Inc is a health benefits company. The Company operates through three segments: Commercial and Specialty Business, Government Business and Other. It offers a spectrum of network-based managed care plans to large and small employer, individual, Medicaid and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; indemnity plans and other hybrid plans, including consumer-driven health plans; and hospital only and limited benefit products.
Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.